大剂量口服左甲状腺素片分次治疗作为黏液性水肿昏迷的一种成功治疗选择。
Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma.
作者信息
Charoensri Suranut, Sriphrapradang Chutintorn, Nimitphong Hataikarn
机构信息
Division of Endocrinology and Metabolism Department of Medicine Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok 10400 Thailand.
Division of Endocrinology and Metabolism Department of Medicine Faculty of Medicine Khon Kaen University Khon Kaen 40002 Thailand.
出版信息
Clin Case Rep. 2017 Sep 8;5(10):1706-1711. doi: 10.1002/ccr3.1131. eCollection 2017 Oct.
High-dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69-year-old man who presented with myxedema coma and received oral levothyroxine (LT4) therapy (1 mg) in a split dose. This suggests split high-dose oral LT4 as a therapeutic option in myxedema coma.
大剂量静脉注射甲状腺素（T4）是黏液性水肿昏迷的首选治疗方法。我们描述了一名69岁男性黏液性水肿昏迷患者的临床病程，该患者接受了分次口服左甲状腺素（LT4）治疗（1毫克）。这表明分次大剂量口服LT4可作为黏液性水肿昏迷的一种治疗选择。
Zotero 插件